Deucravacitinib
Product Description
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Categories
Specifications
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (62)
-
Product Domperidone EP Impurity A
Intermediate and metabolite of the gastrokinetic and antinauseant drug Domperidone. -
Product Sulfacetamide Sodium
An antibiotic that blocks synthesis of dihydrofolic acid by inhibiting the enzyme dihydropteroate synthase -
Product Tamoxifen
Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor ... -
Product 2,2-Dipyridylamine
A metal-complexing agent; an effective iron chelating agent to help protect against UVB radiation. An impurity of Chlorpheniramine Maleate . ;Impurity in commercial preparations of Chlorpheniramine. -
Product Tert-butanol-d9
Tert-Butanol-d₉ ((CD₃)₃COD) is a high-purity deuterated solvent and versatile isotope-labeled building block used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient incorporation of deuterated tert-butyl groups into target... -
Product Bromocyclopentane-d9
Bromocyclopentane-d₉ is a high-purity deuterated alkyl bromide widely used as a versatile building block in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated cyclopentyl group into complex organi... -
Product Deutetrabenazine
Deutetrabenazine is a first-in-class, orally bioavailable deuterated vesicular monoamine transporter 2 (VMAT2) inhibitor approved for the treatment of chorea associated with Huntington’s disease and tardive dyskinesia. -
Product Deutivacaftor
Deutivacaftor is an orally active, deuterated cystic fibrosis transmembrane conductance regulator (CFTR) potentiator designed to improve salt and water transport across cell membranes. As a deuterium-substituted analogue of ivacaftor, it utilizes targeted carbon-deuterium bonds to resist CYP3A-mediat... -
Product Methyl boronic-d3
Methylboronic Acid-d₃ (CD₃B(OH)₂) is a high-purity deuterated organoboron building block widely used in the synthesis of stable isotope-labeled pharmaceuticals, advanced intermediates, and analytical reference standards. It is an essential reagent for Suzuki–Miyaura cross-coupling reactions, enabling the e... -
Product Methyl iodide-d3
Methyl iodide-d₃ (CD₃I) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, metabolites, and analytical reference standards. It enables the efficient incorporation of a deuterated methyl (–CD₃) group into complex organic mol... -
Product Methyl tosylate-d3
Methyl Tosylate-d₃ (CD₃OTs) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated methyl (–CD₃) group into target molecules, making it a... -
Product Methylamine-d3 HCl
Methylamine-d₃ Hydrochloride serves as a key deuterated building block for introducing a CD₃-labeled methylamine moiety into complex organic molecules. It is extensively used in the preparation of deuterated drug candidates, impurities, and metabolites, including compounds such as: Deucravacitinib-d₃ ...
CLEARSYNTH LABS LIMITED resources (1)
-
Video Clearsynth Intro Video
Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.











